FrieslandCampina Ingredients has signed a deal with specialist biotechnology company, Triplebar Bio Inc, to develop and increase the production of cell-based proteins using precision fermentation.
FrieslandCampina Ingredients has been using precision fermentation since 2016 to produce human milk oligosaccharides (HMOs). The company now plans to produce alternative protein solutions using the latest precision fermentation technology.
Triplebar specialises in bioengineering at speed to develop solutions for the nutrition and healthcare industries. It uses hardware, software, biology and biochemistry to develop products and biological production systems that replicate and accelerate evolution found in nature.
The two companies will produce microbial cells through precision fermentation that can create bioactive proteins that support human health and nutrition in early life and adulthood.
The ambition of both companies is to manufacture proteins for use in various applications at scale and with a limited land, water and energy footprint.
'Access To Nutritional Solutions'
“We are continuously exploring new ways that technology and nature can be harnessed to support consumers with special dietary needs – at every stage of life,” said managing director innovation at FrieslandCampina Ingredients, Anne Peter Lindeboom.
“Together, I’m certain that FrieslandCampina Ingredients and Triplebar will accelerate the use of precision fermentation as a nutritious and sustainable source of protein. By offering a full range of dairy and alternative proteins side by side, we aim to give people access to the nutritional solutions they need now and for generations to come,” she added.
FrieslandCampina launched its first plant protein range, Plantaris, in partnership with AGT Foods in November 2021.
© 2023 European Supermarket Magazine – your source for the latest technology news. Article by Robert McHugh. Click subscribe to sign up to ESM: European Supermarket Magazine.